Investing Smart: Bristol-Myers Squibb (BMY) Among the Best Affordable Dividend Stocks

Bristol-Myers Squibb Company (NYSE:BMY) is included among the 11 Best Affordable Dividend Stocks to Buy Now.

Investing Smart: Bristol-Myers Squibb (BMY) Among the Best Affordable Dividend Stocks

Bristol-Myers Squibb Company (NYSE:BMY) is an American pharmaceutical giant that operates in multiple countries and is based in New Jersey. In the second quarter, the company’s growth portfolio recorded double-digit sales, and at least seven products recorded more than 20% sales increase. Among them, cancer cell therapy Breyanzi has more than doubled its sales in the period.

In the quarters ahead, investors can look forward to surging sales of Cobenfy. This new schizophrenia treatment earned approval from the Food and Drug Administration last September, and sales are expected to reach $2.6 billion by 2030.

This year, the big pharma company expects earnings to land in a range between $6.35 and $6.65 per share. That’s heaps more than it needs to meet a dividend commitment currently set at an annualized $2.48 per share. With a strong lineup of new products to offset losses due to upcoming patent expirations, its high-yield dividend could keep growing for at least another decade.

Bristol-Myers Squibb Company (NYSE:BMY) has raised its dividends for 16 consecutive years. The company pays a per-share dividend of $0.62 every quarter and has a dividend yield of 5.39%, as of October 2.

While we acknowledge the potential of BMY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than BMY and that has a 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 12 Best REIT Dividend Stocks to Buy Now and 10 Highest Dividend-Paying Stocks to Buy in the S&P 500.

Disclosure: None.